Table 2.
Serum differential metabolites in epileptic patients in basal and post-seizure state. The table highlights metabolites with significant alterations in epileptic patients in basal and post-seizure state. Each metabolite is presented with its false discovery rate (FDR) from Wilcoxon rank-sum test, area under the curve (AUC) values with 90% confidence intervals (CI), log2 fold-change values and PLS-DA VIP scores.
| Metabolite | Basal vs. post-seizure state | ||||
|---|---|---|---|---|---|
| FDR | AUC | 90% CI | Log 2 Fold-Change | VIP score | |
| Isovaleric acid | 0.000005 | 0.846 | 0.733–0.926 | 2.12 | 1.91 |
| Pyroglutamic acid | 0.000005 | 0.842 | 0.741–0.930 | 1.08 | 3.08 |
| 2-Oxoisocaproic acid | 0.000038 | 0.811 | 0.683–0.918 | -0.45 | 1.32 |
| Hippuric acid | 0.008372 | 0.800 | 0.617–0.863 | 0.77 | 1.86 |
| 3-Methyl-2-Oxovaleric acid | 0.015174 | 0.730 | 0.582–0.846 | 0.91 | 1.45 |
| Creatinine | 0.026862 | 0.715 | 0.595–0.843 | 0.24 | 1.32 |
| Threonine | 0.049891 | 0.695 | 0.537–0.806 | 0.37 | 1.25 |